Compare PBHC & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBHC | SEER |
|---|---|---|
| Founded | 1859 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.8M | 97.3M |
| IPO Year | 2014 | 2020 |
| Metric | PBHC | SEER |
|---|---|---|
| Price | $13.55 | $1.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.6K | ★ 345.2K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | ★ 46.25 | 9.40 |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $29.15 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $12.06 | $1.65 |
| 52 Week High | $15.96 | $2.41 |
| Indicator | PBHC | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 58.08 |
| Support Level | $13.53 | $1.87 |
| Resistance Level | $13.75 | $1.97 |
| Average True Range (ATR) | 0.27 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 65.84 | 97.92 |
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.